These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36628831)

  • 1. Airway bacterial community composition in persons with advanced cystic fibrosis lung disease.
    Thornton CS; Carmody LA; Kalikin LM; Opron K; Caverly LJ; LiPuma JJ
    J Cyst Fibros; 2023 Jul; 22(4):623-629. PubMed ID: 36628831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis.
    Vieira J; Jesudasen S; Bringhurst L; Sui HY; McIver L; Whiteson K; Hanselmann K; O'Toole GA; Richards CJ; Sicilian L; Neuringer I; Lai PS
    mSystems; 2022 Oct; 7(5):e0036422. PubMed ID: 36000724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild Cystic Fibrosis Lung Disease Is Associated with Bacterial Community Stability.
    Hampton TH; Thomas D; van der Gast C; O'Toole GA; Stanton BA
    Microbiol Spectr; 2021 Sep; 9(1):e0002921. PubMed ID: 34232099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.
    Armbruster CR; Li K; Kiedrowski MR; Zemke AC; Melvin JA; Moore J; Atteih S; Fitch AC; DuPont M; Manko CD; Weaver ML; Gaston JR; Alcorn JF; Morris A; Methé BA; Lee SE; Bomberger JM
    Microbiol Spectr; 2022 Oct; 10(5):e0125122. PubMed ID: 36094193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.
    Carmody LA; Zhao J; Schloss PD; Petrosino JF; Murray S; Young VB; Li JZ; LiPuma JJ
    Ann Am Thorac Soc; 2013 Jun; 10(3):179-87. PubMed ID: 23802813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
    Syed SA; Whelan FJ; Waddell B; Rabin HR; Parkins MD; Surette MG
    Ann Am Thorac Soc; 2016 Dec; 13(12):2132-2142. PubMed ID: 27925791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic footprint of the airway bacterial community in cystic fibrosis.
    Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
    Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway.
    Jean-Pierre F; Vyas A; Hampton TH; Henson MA; O'Toole GA
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergence of bacterial communities in the lower airways of CF patients in early childhood.
    O'Connor JB; Mottlowitz MM; Wagner BD; Boyne KL; Stevens MJ; Robertson CE; Harris JK; Laguna TA
    PLoS One; 2021; 16(10):e0257838. PubMed ID: 34613995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.
    Carmody LA; Caverly LJ; Foster BK; Rogers MAM; Kalikin LM; Simon RH; VanDevanter DR; LiPuma JJ
    PLoS One; 2018; 13(3):e0194060. PubMed ID: 29522532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftor.
    Einarsson GG; Ronan NJ; Mooney D; McGettigan C; Mullane D; NiChroinin M; Shanahan F; Murphy DM; McCarthy M; McCarthy Y; Eustace JA; Gilpin DF; Elborn JS; Plant BJ; Tunney MM
    J Cyst Fibros; 2021 Sep; 20(5):747-753. PubMed ID: 33549519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.
    Botterel F; Angebault C; Cabaret O; Stressmann FA; Costa JM; Wallet F; Wallaert B; Bruce K; Delhaes L
    Mycopathologia; 2018 Feb; 183(1):171-183. PubMed ID: 28766039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis.
    Acosta N; Heirali A; Somayaji R; Surette MG; Workentine ML; Sibley CD; Rabin HR; Parkins MD
    Thorax; 2018 Nov; 73(11):1016-1025. PubMed ID: 30135091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
    Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
    Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
    [No Abstract]   [Full Text] [Related]  

  • 17. 16S rRNA gene sequencing reveals site-specific signatures of the upper and lower airways of cystic fibrosis patients.
    Lucas SK; Yang R; Dunitz JM; Boyer HC; Hunter RC
    J Cyst Fibros; 2018 Mar; 17(2):204-212. PubMed ID: 28826586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.
    Hogan DA; Willger SD; Dolben EL; Hampton TH; Stanton BA; Morrison HG; Sogin ML; Czum J; Ashare A
    PLoS One; 2016; 11(3):e0149998. PubMed ID: 26943329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis.
    Carmody LA; Kalikin LM; VanDevanter DR; Li G; Opron K; Simon RH; Caverly LJ; LiPuma JJ
    J Cyst Fibros; 2022 Sep; 21(5):766-768. PubMed ID: 35667975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.